Evidence map›Paper›PMID 34917094›Full record

Observational studyFrontiers in immunology2021

Attenuated Negative Feedback in Monocyte-Derived Macrophages From Persons Living With HIV: A Role for IKAROS.

Celeste Faia, Karlie Plaisance-Bonstaff, Cecilia Vittori, Dorota Wyczechowska, Adam Lassak, Mary Meyaski-Schluter, Krzysztof Reiss, Francesca Peruzzi

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Celeste FaiaDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Karlie Plaisance-BonstaffStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Cecilia VittoriStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Dorota WyczechowskaStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Adam LassakStanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Mary Meyaski-SchluterClinical and Translational Research Center, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Krzysztof ReissDepartment of Interdisciplinary Oncology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Francesca PeruzziDepartment of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
Louisiana State University Health Sciences Center New Orleans · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Translational Genomics Core (TGC)P20GM121288 · NIGMS · LSU HEALTH SCIENCES CENTER · PI Arunava Roy · 2017 to 2026
$22.4M
Translational Genomics CoreP30GM114732 · NIGMS · LSU HEALTH SCIENCES CENTER · PI OCHOA, AUGUSTO C. · 2015 to 2019
$5.2M
NIGMS NIH HHS P20 GM121288NIGMS NIH HHS P30 GM114732NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Persons living with HIV (PLWH) are at higher risk of developing secondary illnesses than their uninfected counterparts, suggestive of a dysfunctional immune system in these individuals. Upon exposure to pathogens, monocytes undergo epigenetic remodeling that results in either a trained or a tolerant phenotype, characterized by hyper-responsiveness or hypo-responsiveness to secondary stimuli, respectively. We utilized CD14

Indexed as

Anti-HIV AgentsCase-Control StudiesCytokinesDisease SusceptibilityFeedback, PhysiologicalFemaleGene Expression RegulationHealthy VolunteersHIVHIV InfectionsHumansIkaros Transcription FactorInflammationLipopolysaccharidesMacrophagesMaleAnti-HIV AgentsCytokinesIkaros Transcription FactorIKZF1 protein, humanLipopolysaccharidesRELA protein, humanTranscription Factor RelAendotoxin toleranceHIV-1Ikarosimmune dysfunctionmonocytes

Identifiers

PMID34917094
PMCPMC8668949
OpenAlexW3217461352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.